Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests

Introduction: Imatinib, a tyrosine kinase inhibitor which resulted in much improvement in the treatment of chronic myelogenous leukemia (CML), may adversely affect thyroid gland function. To date, assessment of thyroid function during imatinib therapy has limited to retrospective studies. The aim of...

Full description

Bibliographic Details
Published in:International Journal of Hematology-Oncology and Stem Cell Research
Main Authors: Mohammad Ali Mashhadi, Mahmoud Ali Kaykhaei, Mahdi Mohammadi, Mahdi Hashemi, Tahere Mohamadi Fatide
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2014-09-01
Subjects:
Chronic myelogenous leukemia
Imatinib mesylate
Thyroid function tests
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/417

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/417

Similar Items